Results 21 to 30 of about 1,330,157 (395)

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

Alzheimer’s Research & Therapy, 2018
Background The study investigated whether donepezil exerts symptomatic benefit in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer’s disease.
Basil H. Ridha, Sebastian Crutch, Dawn Cutler, Christopher Frost, William Knight, Suzie Barker, Norah Epie, Elizabeth K. Warrington, Riitta Kukkastenvehmas, Jane Douglas, Martin N. Rossor   +10 more
doaj   +1 more source

Dementia Prevalence Estimates in Sub-Saharan Africa: Comparison of two Diagnostic Criteria. [PDF]

, 2013
We have previously reported the prevalence of dementia in older adults living in the rural Hai district of Tanzania according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria.
Chaote, Paul, Dewhurst, Felicity, Dotchin, Catherine, Gray, William K, Jusabani, Ahmed M, Kalaria, Raj, Kisoli, Aloyce, Longdon, Anna R, Paddick, Stella-Maria, Walker, Richard   +9 more
core   +3 more sources

Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression

npj Parkinson's Disease, 2022
Depression is a common non-motor feature of Parkinson’s disease (PD) which confers significant morbidity and is challenging to treat. The thalamus is a key component in the basal ganglia-thalamocortical network critical to the pathogenesis of PD and ...
R. Bhome, A. Zarkali, G. E. C. Thomas, J. E. Iglesias, J. H. Cole, R. S. Weil   +5 more
doaj   +1 more source

Dementia, music and biometric gaming: Rising to the Dementia Challenge [PDF]

, 2015
In 2012, the U.K. government launched its Dementia Challenge, authorizing additional funding for dementia research and health care. The search for curative medicines is ongoing, but scientific research reveals evidence that music can play a positive role
Guétin S., Helen R. Mitchell, Kubota N.
core   +1 more source

Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. [PDF]

, 2010
INTRODUCTION: Evidence from clinical samples and geographically limited population studies suggests that vascular health, diabetes and apolipoprotein epsilon4 (APOE) are associated with dementia. METHODS: A population-based sample of 856 individuals aged
Fisher, Gwenith G, Kabeto, Mohammed U, Lang, Iain A, Langa, Kenneth M, Llewellyn, David J, Matthews, Fiona E, Morgenstern, Lewis B, Plassman, Brenda L, Rogers, Mary A   +8 more
core   +5 more sources

Understanding the training and education needs of homecare workers supporting people with dementia and cancer: a systematic review of reviews [PDF]

, 2020
Many people with dementia, supported by family carers, prefer to live at home and may rely on homecare support services. People with dementia are also often living with multimorbidities, including cancer. The main risk factor for both cancer and dementia
Alzheimer’s Society, Bennett L., Clarkson P., D’Astous V., Eden J., Hall P., Hughes S., Jefferson L., Julie Cowie, Karen Methven, Karen Watchman, Loannidis J., McWilliams L., Montori V., National Audit Office., Nicola Cunningham, Poblador-Plou B., Pollock M., Witham G.   +18 more
core   +3 more sources

Factors associated with successful dementia education for practitioners in primary care: an in-depth case study

BMC Medical Education, 2019
Background With increasing numbers of people in the UK living with dementia, the provision of good quality person-centred care that meets the often complex needs of this population is required.
Cara Sass, Natasha Burnley, Michelle Drury, Jan Oyebode, Claire Surr   +4 more
doaj   +1 more source

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

Alzheimer's & Dementia, 2022
People with type 2 diabetes have increased risk of dementia. Glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswered question is whether they ...
C. H. Nørgaard, Sarah Friedrich, C. T. Hansen, T. Gerds, C. Ballard, D. Møller, L. Knudsen, K. Kvist, B. Zinman, E. Holm, C. Torp‐Pedersen, Lina Steinrud Mørch   +11 more
semanticscholar   +1 more source

A roadmap to develop dementia research capacity and capability in Pakistan: a model for low- and middle-income countries [PDF]

, 2019
Objective To produce a strategic roadmap for supporting the development of dementia research in Pakistan. Background While global research strategies for dementia research already exist, none is tailored to the specific needs and challenges of low ...
Ambily Sathish, Anna Daniel, Asad Tamizudin, Aysha Khaliq, Hussain Jafri, Iracema Leroi, Mohammad Wasay, Mohammed Jafri, Mowadat Hussain Rana, Murad Khan, Nasim Chaudhry, Nicolas Farina, Nusrat Husain, Pakistan Dementia Research Stakeholder Group (PDRSG), Quratulain Khan, Raheel Karim, Rakhshi Memon, Ross Dunne, Sadaf Eitesam, Saima Eman, Saima Nafis, Saima Sheikh, Salman Karim, Sana‐e‐Zehra Haidry, Sehrish Tofique, Shakil Jehangir Malik, Tayyeba Kiran, Yasser Abbasi, Zainab Zadeh   +28 more
core   +1 more source

Drawn from life: Cocreating narrative and graphic vignettes of lived experience with people affected by dementia

Health Expectations, 2021
Background The growing literature on Patient and Public Involvement and Engagement (PPIE) and dementia identifies specific problems related to the influence that involvement has on research outcomes, over‐reliance on family members as proxies and lack of
Andrea Capstick, Alison Dennison, Jan Oyebode, Lesley Healy, Claire Surr, Sahdia Parveen, Cara Sass, Michelle Drury   +7 more
doaj   +1 more source